ANNX - Annexon, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - ANNX (1528115)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
32 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-10-15
ANNXYednock TedEVP, CHIEF INNOVATION OFFICERS - Sale+OE$7.41-5,40871,365-7%-$40,073
2024-10-01
ANNXCarson William H.DirP - Purchase$5.97+3,20022,400+17%+$19,104
2024-09-19
ANNXYednock TedEVP, CHIEF INNOVATION OFFICERS - Sale$7.10-4,50071,365-6%-$31,950
2024-09-12
ANNXYednock TedEVP, CHIEF INNOVATION OFFICERS - Sale$6.16-5,50075,865-7%-$33,880
2024-09-05
ANNXYednock TedEVP, CHIEF INNOVATION OFFICERS - Sale$5.64-5,50081,365-6%-$31,020
2024-09-03
ANNXCarson William H.DirP - Purchase$5.48+3,20019,200+20%+$17,536
2024-08-29
ANNXYednock TedEVP, CHIEF INNOVATION OFFICERS - Sale$5.95-5,50086,865-6%-$32,725
2024-08-01
ANNXCarson William H.DirP - Purchase$6.24+3,20016,000+25%+$19,968
2024-07-15
ANNXOverdorf MichaelEVP, CHIEF BUSINESS OFFICERS - Sale$6.02-78494,622-1%-$4,720
2024-07-15
ANNXLew JenniferEVP, CFOS - Sale$6.03-1,10486,468-1%-$6,657
2024-07-15
ANNXYednock TedEVP, CHIEF INNOVATION OFFICERS - Sale$6.02-1,10692,365-1%-$6,658
2024-07-01
ANNXCarson William H.DirP - Purchase$5.00+3,20012,800+33%+$16,000
2024-06-03
ANNXCarson William H.DirP - Purchase$4.83+3,2009,600+50%+$15,459
2024-05-01
ANNXCarson William H.DirP - Purchase$4.68+3,2006,400+100%+$14,982
2024-04-08
ANNXCarson William H.DirP - Purchase$6.07+3,2003,200New+$19,411
D
2024-02-20
ANNXLew JenniferEVP, CFOS - Sale+OE$5.53-2,59382,058-3%-$14,339
D
2024-02-20
ANNXYednock TedEVP, CHIEF INNOVATION OFFICERS - Sale+OE$5.51-2,60493,471-3%-$14,348
D
2024-02-20
ANNXOverdorf MichaelEVP, CHIEF BUSINESS OFFICERS - Sale+OE$5.48-1,95185,641-2%-$10,691
2024-02-12
ANNXOverdorf MichaelEVP, CHIEF BUSINESS OFFICERS - Sale$5.53-1,34948,592-3%-$7,460
2024-02-12
ANNXLove DouglasPres, CEOS - Sale$5.54-5,782196,121-3%-$32,032
2024-02-12
ANNXLew JenniferEVP, CFOS - Sale$5.54-1,80945,651-4%-$10,022
2024-02-12
ANNXYednock TedEVP, CHIEF INNOVATION OFFICERS - Sale$5.54-1,81057,075-3%-$10,027
AM
2023-07-11
ANNXYednock TedEVP, Chief Innovation OfficerS - Sale$4.49-22,05758,885-27%-$99,021
2023-07-11
ANNXOverdorf MichaelEVP, Chief Business OfficerS - Sale$3.84-97845,802-2%-$3,752
2023-07-11
ANNXLew JenniferEVP, CFOS - Sale$3.84-1,05747,460-2%-$4,055
D
2023-12-27
ANNXYednock TedEVP, Chief Innovation OfficerS - Sale+OE$4.52-21,0000-100%-$94,966
2023-12-26
ANNXSatter Muneer ADir, 10%P - Purchase$2.88+350,0007,406,024+5%+$1,008,000
2023-05-25
ANNXBain Capital Life Sciences Investors, LLC10%P - Purchase$2.13+300,0005,701,926+6%+$639,720
2023-02-15
ANNXLove DouglasPres, CEOS - Sale$5.87-6,571197,646-3%-$38,564
M
2023-02-13
ANNXOverdorf MichaelEVP, Chief Business OfficerS - Sale$6.30-1,64527,805-6%-$10,368
M
2023-02-13
ANNXLew JenniferEVP, CFOS - Sale$6.31-1,90829,542-6%-$12,035
2023-02-10
ANNXSatter Muneer ADir, 10%P - Purchase$6.80+2,647,0587,056,024+60%+$17,999,994

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top